174 related articles for article (PubMed ID: 26692526)
1. Sensorineural Hearing Loss after Combined Intensity Modulated Radiation Therapy and Cisplatin-Based Chemotherapy for Nasopharyngeal Carcinoma.
Wang J; Chen YY; Tai A; Chen XL; Huang SM; Yang C; Bao Y; Li NW; Deng XW; Zhao C; Chen M; Li XA
Transl Oncol; 2015 Dec; 8(6):456-62. PubMed ID: 26692526
[TBL] [Abstract][Full Text] [Related]
2. Dosimetric parameters associated with conductive or sensorineural hearing loss 5 years after intensity-modulated radiation therapy in nasopharyngeal carcinoma.
Zhu W; Chen F; Li J; Wang W; Zhang H; Yang G; Zou L; Zhu Y; Yuan W; Ding H; Song X; Wang S
Acta Otolaryngol; 2019 Mar; 139(3):263-268. PubMed ID: 30870056
[TBL] [Abstract][Full Text] [Related]
3. Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma.
Chen WC; Jackson A; Budnick AS; Pfister DG; Kraus DH; Hunt MA; Stambuk H; Levegrun S; Wolden SL
Cancer; 2006 Feb; 106(4):820-9. PubMed ID: 16421885
[TBL] [Abstract][Full Text] [Related]
4. Sensorineural Hearing Loss in Nasopharyngeal Carcinoma Survivors in the Modern Treatment Era - The Early and Late Effects of Radiation and Cisplatin.
Yip PL; Mok KCJ; Ho HS; Lee WYV; Wong ACL; Lau CT; Wong FCS; Yeung KW; Lee SF
Clin Oncol (R Coll Radiol); 2022 Apr; 34(4):e160-e167. PubMed ID: 34772581
[TBL] [Abstract][Full Text] [Related]
5. Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis.
Chan SH; Ng WT; Kam KL; Lee MC; Choi CW; Yau TK; Lee AW; Chow SK
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1335-42. PubMed ID: 18922648
[TBL] [Abstract][Full Text] [Related]
6. Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: a prospective study of the effect of radiation and cisplatin treatment.
Kwong DL; Wei WI; Sham JS; Ho WK; Yuen PW; Chua DT; Au DK; Wu PM; Choy DT
Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):281-9. PubMed ID: 8892450
[TBL] [Abstract][Full Text] [Related]
7. Sensorineural hearing loss after concurrent chemoradiotherapy in nasopharyngeal cancer patients.
Petsuksiri J; Sermsree A; Thephamongkhol K; Keskool P; Thongyai K; Chansilpa Y; Pattaranutaporn P
Radiat Oncol; 2011 Feb; 6():19. PubMed ID: 21333025
[TBL] [Abstract][Full Text] [Related]
8. Impact of radiation technique, radiation fraction dose, and total cisplatin dose on hearing : Retrospective analysis of 29 medulloblastoma patients.
Scobioala S; Parfitt R; Matulat P; Kittel C; Ebrahimi F; Wolters H; Am Zehnhoff-Dinnesen A; Eich HT
Strahlenther Onkol; 2017 Nov; 193(11):910-920. PubMed ID: 28887665
[TBL] [Abstract][Full Text] [Related]
9. Short-term cohort study on sensorineural hearing changes in head and neck radiotherapy.
Cheraghi S; Nikoofar P; Fadavi P; Bakhshandeh M; Khoie S; Gharehbagh EJ; Farahani S; Mohebbi A; Vasheghani M; Zare M; Nikoofar A; Mahdavi SR
Med Oncol; 2015 Jul; 32(7):200. PubMed ID: 26071124
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Progression of Sensorineural Hearing Loss and Tinnitus after Combined Intensity-Modulated Radiation Therapy and Cisplatin-Based Chemotherapy for Nasopharyngeal Carcinoma: A Case Report.
Lee MS; Penumala S; Sweet S; De Luca RR; Stearnes AE; Akgun Y
Case Rep Oncol; 2017; 10(2):743-751. PubMed ID: 28878660
[TBL] [Abstract][Full Text] [Related]
11. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
Das N; Kaushal D; Patro SK; Pareek P; Dixit A; Soni K; Prakasan Nair N; Choudhury B; Goyal A
Acta Otolaryngol; 2021 Sep; 141(9):885-893. PubMed ID: 34486907
[TBL] [Abstract][Full Text] [Related]
12. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
Hitchcock YJ; Tward JD; Szabo A; Bentz BG; Shrieve DC
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):779-88. PubMed ID: 18707819
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of sensorineural hearing loss in nasopharyngeal carcinoma patients: comparison between treatment with radiotherapy alone and chemoradiotherapy.
Wei Y; Zhou T; Zhu J; Zhang Y; Sun M; Ding X; Wang D; Li H; Li B
Cell Biochem Biophys; 2014 Jul; 69(3):433-7. PubMed ID: 24510513
[TBL] [Abstract][Full Text] [Related]
14. Thyroid V40 Predicts Primary Hypothyroidism After Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma.
Sommat K; Ong WS; Hussain A; Soong YL; Tan T; Wee J; Fong KW
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):574-580. PubMed ID: 28581397
[TBL] [Abstract][Full Text] [Related]
15. Comparison of radiation and chemoradiation-induced sensorineural hearing loss in head and neck cancer patients.
Mahdavi SR; Rezaeyan A; Nikoofar A; Bakhshandeh M; Farahani S; Cheraghi S
J Cancer Res Ther; 2020; 16(3):539-545. PubMed ID: 32719264
[TBL] [Abstract][Full Text] [Related]
16. Risk Profiles for Sensorineural Hearing Loss in Patients with Head and Neck Cancer Receiving Cisplatin-based Chemoradiation.
Shorter P; Harden F; Owen R; Panizza B; Burmeister B; Sommerville J; Mengersen K; Foote M
J Med Imaging Radiat Sci; 2017 Mar; 48(1):61-67. PubMed ID: 31047212
[TBL] [Abstract][Full Text] [Related]
17. Prediction of Hearing Loss Due to Cisplatin Chemoradiotherapy.
Theunissen EA; Zuur CL; Józwiak K; Lopez-Yurda M; Hauptmann M; Rasch CR; van der Baan S; de Boer JP; Dreschler WA; Balm AJ
JAMA Otolaryngol Head Neck Surg; 2015 Sep; 141(9):810-5. PubMed ID: 26291150
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric analysis of hearing loss after cranial radiation therapy in children: A single-institution study from the French national registry PediaRT.
Gehin W; Chastagner P; Mansuy L; Bernier-Chastagner V
Radiother Oncol; 2024 May; 197():110346. PubMed ID: 38806115
[TBL] [Abstract][Full Text] [Related]
19. Sensory neural hearing loss after concurrent cisplatin and radiation therapy for nasopharyngeal carcinoma.
Oh YT; Kim CH; Choi JH; Kang SH; Chun M
Radiother Oncol; 2004 Jul; 72(1):79-82. PubMed ID: 15236878
[TBL] [Abstract][Full Text] [Related]
20. SmartArc-based volumetric modulated arc therapy can improve the middle ear, vestibule and cochlea sparing for locoregionally advanced nasopharyngeal carcinoma: a dosimetric comparison with step-and-shoot intensity-modulated radiotherapy.
Gao J; Qian TL; Tao CZ; Zhang YH; Zhou Y; Yang J; He J; Wang R; Zhou PJ
Br J Radiol; 2015 Sep; 88(1053):20150052. PubMed ID: 26111068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]